Clinical Pathways Search Results

The inpatient anaphylaxis pathway takes a step-by-step approach to the evaluation and treatment of a child with a of history anaphylaxis.

The neuromuscular scoliosis spinal fusion clinical pathways standardizes the perioperative management of patients with neuromuscular scoliosis following posterior spinal fusion.

The vascular access clinical pathway outlines the care plan for vascular access initiation and management in the inpatient setting.

This pathway is used to evaluate the treatment of the child with suspected acquired aplastic anemia.

The clinical pathway for child with fever guides early identification, evaluation and management of patients with high-risk factors or severe signs/symptoms of disease.

The Outpatient Specialty Care and Primary Care Coronavirus Pathway provides guidance for the evaluation and care of patients with laboratory-confirmed 2019-nCoV or who is under investigation for 2019-nCoV while that patient was ill.

The Prevention of Acute Chemotherapy-Induced Nausea and Vomiting Clinical Pathway provides guidance for selecting anti-emetics and non-pharmacologic therapies for patients receiving chemotherapy.

Treatment of patients with active COVID-19 disease with guidance on severity of illness, recommendations for antivirals, steroids, immunomodulators, and convalescent plasma administration.

The Beckwith-Wiedemann Syndrome (BWS) Clinical Pathway provides guidance of care for neonates/infants born at the CHOP SDU or referred from outside institutions for further evaluation and treatment with overgrowth features such as macroglossia, hyperinsulinism, omphalocele and/or a constellation of findings suspicious for BWS.

The neonatal abstinence syndrome (NAS)/neonatal opioid withdrawal syndrome (NOWS) clinical pathway provides a care plan to optimize non-pharmacologic management for infants and maximize maternal-infant bonding